(PDF) Impact of Price Regulation of Biologic Therapies for

Impact of Price Regulation of Biologic Therapies for Rheumatoid Arthritis in Colombia – A Cost Minimization Analysis

Value in Health - United Kingdom

doi 10.1016/j.jval.2014.03.285

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

May 1, 2014

Authors

R. Alfonso-Cristancho

O.D. Diaz-Sotelo

D.A. Jaimes Fernández

S. Garrido Lecca

Publisher

Elsevier BV

Related search

Pms24 - Cost Minimization Analysis of Third Line Rheumatoid Arthritis Drugs in Ecuador

Value in Health

Occupational Health

English

Biologic Treatments for Rheumatoid Arthritis

Trends in Urology & Men's Health

English

Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)

Value in Health

Occupational Health

English

Non-Tumor Necrosis Factor-Based Biologic Therapies for Rheumatoid Arthritis: Present, Future, and Insights Into Pathogenesis

Biologics: Targets and Therapy

Gastroenterology

English

PMS12 a Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid Arthritis in Italy

Value in Health

Occupational Health

English

Biologic Refractory Disease in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Annals of the Rheumatic Diseases

Molecular Biology

English

Persistence With Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan

Patient Preference and Adherence

Social Sciences

English

Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany

Value in Health

Occupational Health

English

Therapies for Active Rheumatoid Arthritis After Methotrexate Failure

Rheumatology: Current Research

English